The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.

People are injecting peptides to build muscle, trim fat, and reduce inflammation. Does it work?

The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...

Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...

Clad in a skintight taupe bodysuit, the outfit accentuated Chyna's incredibly flat abs, toned legs and defined arms.

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

A spokesperson said: “Results from the STEP trials demonstrate that weight regain is likely once medication is stopped.

But now, researchers have turned a fresh eye to another medication originally designed to treat type 2 diabetes: metformin. While it was once “just” a medication for people with type 2 diabetes, ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

When you hear the name Ozempic, you likely think of diabetes treatment. That makes sense, as semaglutide was first approved in 2017 to help people with type 2 diabetes regulate […] ...